1. Barr Wh, Lin C-C, Radwanski E., Lim J., Symchowicz S. 1991. The Pharmacokinetics of Ceftibuten in Humans — Diagnostic Microbiology & Infectious Diseases 14:93–100.
2. Barry AL, Jones RN - 1990. The Collaborative Antimicrobial Susceptibility Testing Group-Interpretivecriteria & quality control limits for Ceftibuten disk susceptibility tests - J. Clinical Microbiology 28:605–607.
3. Bauemfeind A- 1991. Ceftibuten & Dactericidal kinetics. Comparative invitro activity againstenterobacteriaceae producing extended spectrum B-lactamases - Diagnostic Microbiology& Infections Dieseases 14:89–92.
4. Blummer JL, McLinn SE, DeAbate CA, Kafetzis DA, Perrotta RJ - 1993. Multinationalmulticenter controlled trial comparing Ceftibuten with Cefactor for the treatment of AcuteOtitis Media - Paediatric Infectious Disease Journal 12 (Suppl): S77-S83.
5. DeAbate CA, Prerrotta RJ, Dennington ML, Ziering RM - 1993. The efficacy & safety ofonce daily Ceftibuten compared with co-amoxiclav in the treatment of acute bacterialsinusitis - /. Chemotherapy 4:358–363.